Sunday, February 01, 2015 6:09:47 PM
"PolyMedix says it identified its lead drug candidate in less than 18 months for less than $2 million. The company believes it can have its first antibiotic drug on the market in five to six years, for about $100 million. It has created 12 classes of antibiotics and selected several of them as candidates for human trials, Mr. Landekic said. "We've shown that they kill more than 80 different strains of bacteria. Actually, we haven't found any strain of bacteria that we haven't been able to kill with these compounds," Mr. Landekic said. The compounds have been effective on the biowarfare pathogens black plague, tularemia and 12 strains of anthrax, he said."
The implication of CTIX possessing 12 classes of antibiotics is, to put it simply, mind boggling as there have only been 2 new classes of antibiotics developed since 1962. Here is a list of antibiotic classes:
http://en.wikipedia.org/wiki/List_of_antibiotics
As a side note: Couldn't help but notice someone added Teixobactin at the end as an antibiotic candidate. I wish I knew how to add Brilacidin in that section as a new class candidate far ahead of Teixobactin. Who knows, maybe someone on the board knows how to edit Wikipedia.
Anyway, back to the quote - I think it is more likely the reference is to twelve new molecules and I am hesitant to believe each represents a new class. I do not know this for sure as the article says classes but it is a newspaper article, albeit the WSJ, which, while a good paper, lacks the rigor of an academic journal article. Also, when the polyheist occurred, there was mention of a discrete number of molecules (I seem to recall 18 or something like that) but this is the first I have seen reference to 12 classes.
All of which raises the question as to whether subsequent work eliminated many of them or, alternatively, are they hiding down there in the patents etc. and have the potential to surface as future viable drug candidates and additional classes with analogues. If they are there - well, I don't know quite what to say.
Recent IPIX News
- Form 8-K - Current report • Edgar (US Regulatory) • 02/01/2024 01:30:25 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/05/2023 09:25:58 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/20/2023 09:05:44 PM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 11/15/2023 01:00:19 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2023 08:15:25 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 09/28/2023 01:00:08 PM
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM
VAYK Exited Caribbean Investments for $320,000 Profit • VAYK • Jun 27, 2024 9:00 AM
North Bay Resources Announces Successful Flotation Cell Test at Bishop Gold Mill, Inyo County, California • NBRI • Jun 27, 2024 9:00 AM
Branded Legacy, Inc. and Hemp Emu Announce Strategic Partnership to Enhance CBD Product Manufacturing • BLEG • Jun 27, 2024 8:30 AM
POET Wins "Best Optical AI Solution" in 2024 AI Breakthrough Awards Program • POET • Jun 26, 2024 10:09 AM
HealthLynked Promotes Bill Crupi to Chief Operating Officer • HLYK • Jun 26, 2024 8:00 AM